Literature DB >> 31078054

Immunogenicity and protective efficacy of mucosal delivery of recombinant hcp of Campylobacter jejuni Type VI secretion system (T6SS) in chickens.

Ankita Singh1, Khairun Nisaa1, Sudipta Bhattacharyya1, Amirul Islam Mallick2.   

Abstract

The type VI secretion system (T6SS) has recently emerged as a new pattern of protein secretions in Campylobacter jejuni (C. jejuni). Within the T6SS cluster, hemolysin co-regulated protein (hcp) is considered as a hallmark of functional T6SS and holds key role in bacterial virulence. As poultry is the primary reservoir of C. jejuni and the major sources for human infection, we evaluated the capacity of recombinant hcp (rhcp) immunization in blocking C. jejuni colonization in chickens with an aim to control bacterial transmission to humans via poultry food chain. Considering the mucosal route is the primary portal for C. jejuni entry and gut mucosa offers the apposite site for C. jejuni adherence, we investigated the immune-protective potential of intra-gastric administration of rhcp using chitosan-based nanoparticles. To achieve this goal, full length coding sequence of hcp gene from C. jejuni was cloned and expressed in E. coli. Purified rhcp was entrapped in chitosan-Sodium tripolyphosphate nanoparticles (CS-TPP NPs) and orally gavaged in chickens. Our results suggest that intra-gastric immunization of CS-TPP-rhcp induces consistent and steady increase in intestinal (sIgA) and systemic antibody (IgY) response against rhcp with significant reduction in cecal load of C. jejuni. The protection afforded by rhcp associated cellular responses with Th1 and Th17 profile in terms of increased expression of NFkB, IL-1β, IL-8, IL-6, IFN-γ and IL-17 A genes. Though systemic immunization of rhcp with IFA resulting in a robust systemic (IgY) and local (sIgA) antibody response, mucosal administration of rhcp loaded CS-TPP NPs was found to be superior in terms of bacterial clearance. Altogether, present study suggests that chitosan based intra-gastric delivery of rhcp have several advantages over the injectable composition and could be a promising vaccine approach to effectively control C. jejuni colonization in chickens.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Campylobacter jejuni; Chickens; Chitosan nanoparticles; Hemolysin co-regulated protein; Mucosal immunity

Mesh:

Substances:

Year:  2019        PMID: 31078054     DOI: 10.1016/j.molimm.2019.04.016

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  6 in total

Review 1.  Immunomodulation as a Novel Strategy for Prevention and Treatment of Bordetella spp. Infections.

Authors:  Monica C Gestal; Hannah M Johnson; Eric T Harvill
Journal:  Front Immunol       Date:  2019-12-13       Impact factor: 7.561

Review 2.  Chitosan Nanoparticle Based Mucosal Vaccines Delivered Against Infectious Diseases of Poultry and Pigs.

Authors:  Sankar Renu; Gourapura J Renukaradhya
Journal:  Front Bioeng Biotechnol       Date:  2020-11-13

3.  Virulence of the emerging pathogen, Burkholderia pseudomallei, depends upon the O-linked oligosaccharyltransferase, PglL.

Authors:  Samuel J Willcocks; Carmen Denman; Felipe Cia; Elizabeth McCarthy; Jon Cuccui; Brendan W Wren
Journal:  Future Microbiol       Date:  2020-03       Impact factor: 3.165

4.  The cost of bacterial predation via type VI secretion system leads to predator extinction under environmental stress.

Authors:  Subhadeep Gupta; Soumyadipta Ray; Afruja Khan; Arkaprabha China; Dipjyoti Das; Amirul Islam Mallick
Journal:  iScience       Date:  2021-11-26

5.  The Breadth and Molecular Basis of Hcp-Driven Type VI Secretion System Effector Delivery.

Authors:  Sophie A Howard; R Christopher D Furniss; Dora Bonini; Himani Amin; Patricia Paracuellos; David Zlotkin; Tiago R D Costa; Asaf Levy; Despoina A I Mavridou; Alain Filloux
Journal:  mBio       Date:  2021-06-01       Impact factor: 7.867

6.  Bioengineering of LAB vector expressing Haemolysin co-regulated protein (Hcp): a strategic approach to control gut colonization of Campylobacter jejuni in a murine model.

Authors:  Chandan Gorain; Afruja Khan; Ankita Singh; Samiran Mondal; Amirul Islam Mallick
Journal:  Gut Pathog       Date:  2021-07-30       Impact factor: 4.181

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.